Skip to main content

Our Latest News

New research reveals key reasons behind low cancer survival rates in rural Yorkshire

Poor relationships with their GPs and concerns about losing time from work are preventing people in rural areas from seeking help for cancer symptoms, according to new research published in the journal Cancers.

Hope for young cancer patients thanks to clinical trial at Newcastle Hospitals

Two young people with a brain tumour are taking part in a clinical trial at Newcastle Hospitals and so far, the results show real promise.

Changes to chromosomes impact how children’s brain tumours respond to treatment

“Brain tumours are amongst the most difficult-to-treat cancers,” explains Professor Steve Clifford, Chair of Molecular Paediatric Oncology at the University of Newcastle. “It’s especially heartbreaking when they affect children.”

How “chameleon cancers” can change their colours to survive treatment

An international team of scientists has uncovered one of the mechanisms explaining how some leukaemias evade treatment by changing their appearance and identity.

Research into relapse risk in childhood brain cancer could save lives

Scientists led by Newcastle University can identify if a child receiving treatment for brain cancer is at risk of relapsing – and their research could save lives.

Cancer Research UK Innovation Summit 2022

We're delighted to be hosting this year's Cancer Research Horizons Innovation Summit on 26 May. The event will showcase the motives for, and benefits of, translating research through entrepreneurial commercialisation and the support infrastructure available.

Academy of Medical Sciences elects leading Newcastle scientists to its Fellowship

The Academy of Medical Sciences has elected two prominent Newcastle University academics to its Fellowship.

Spin out AMLo Biosciences raises £2.45M for skin cancer test development

The company's “rule-out” prognostic test for early stage skin cancer, can accurately identify genuinely low risk, early-stage melanomas.

Exercise shown to release protein reducing bowel cancer risk

Experts have identified for the first time exactly how exercise can lower your risk of getting bowel cancer and slow the growth of tumours.

Nine-year-old inspired to help children with cancer by her great-aunt

Charlotte Davison has been inspired to help The Little Princess Trust (LPT) by the work of her great aunt who researches kinder treatments for childhood leukaemia.

New hope for treatment of infant cancer

New research has begun to unravel the mystery of why a particular form of leukaemia in infants has defied efforts to improve outcomes, despite significant improvements in treating older children.

Scientists targeting high-grade childhood brain tumour.

New research led by experts at Newcastle University is targeting high-grade childhood brain tumours.

Fund future fertility for childhood cancer patients fairly, say experts.

Young people who survive cancer are at risk of missing out on the chance to have children in the future, due to inequalities in fertility preservation services across the UK, new research has found.

Researcher receives award to target sugars and stop cancer spread.

A Newcastle University researcher has been given a significant award to target sugars and stop the spread of prostate cancer.

Major breakthrough in Neuroblastoma research.

Targeted therapy could be first line treatment for childhood cancer.

From Newcastle Podcast with Professor Ruth Plummer

In this episode we talk to Professor Ruth Plummer, Clinical Professor of Experimental Cancer Medicine at Newcastle University about the ‘Geordie’ cancer drug Rubraca®, a ground-breaking ovarian cancer drug, developed here in Newcastle.

Christine Harrison awarded CRUK grant.

Christine Harrison and her team have been awarded a grant of up to £1m over three years through the Cancer Research UK–Children with Cancer UK Innovation Awards.

Nicola Curtin awarded prestigious international prize.

Nicola Curtin has been awarded a prestigious international prize by the American Society for Pharmacology and Experimental Therapeutics (ASPET).

‘First of its kind’ clinical trial to help lung cancer patients

A group of scientists have been awarded £900,000 from Cancer Research UK to launch a groundbreaking clinical trial for people with lung cancer.

Exploring pharmacists’ role in spotting early signs of oral cancer

Region-wide study unveiled during Mouth Cancer Action Month.

Breakthrough in childhood brain cancer will save lives

A scientific breakthrough has enabled experts to predict relapse in a common childhood cancer and means doctors can tailor treatment for each individual child and improve prognosis.